Regeneron Pharmaceuticals | REGN - Собственный капитал и резервы

Биржевая цена
686.36
Изменение за день
-45.41 -6.21%
Ежемесячно
-8.40%
Ежегодный
14.63%
Q2 прогноз
735.49




Собственный капитал и резервы Изменить Дата
AbbVie USD -3.27B 628M 2025-12
Agenus USD -271.11M 3.03M 2025-12
Agios Pharmaceuticals USD 1.11B 84M 2026-03
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Amgen USD 8.66B 961M 2025-12
Astellas Pharma JPY 1.83T 65.92B 2026-03
AstraZeneca USD 47.33B 1.33B 2026-03
Biogen USD 18.65B 394.9M 2026-03
BioMarin Pharmaceutical USD 6.09B 30.29M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Esperion Therapeutics USD -301.96M 149.4M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Incyte USD 5.62B 455.37M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
J&J USD 81.19B 358M 2026-03
Kyowa Hakko Kirin JPY 893.33B 47.21B 2025-12
Merck USD 51.85B 2.79B 2025-09
Moderna USD 8.65B 680M 2025-12
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Novartis USD 46.13B 1.38B 2025-12
Novartis USD 46.13B 1.8B 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 71.71B 14.25B 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Teva Pharmaceutical Industries USD 7.91B 664M 2025-12
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
United Therapeutics USD 7.1B 506M 2025-12
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12